Non-invasive ventilation in the treatment of early hypoxemic respiratory failure caused by COVID-19: considering nasal CPAP as the first choice
Lili Guan, Luqian Zhou, Jehane Michael Le Grange, Zeguang Zheng, Rongchang Chen
Abstract
19 receiving NIV or HFNO in ICU among different studies. Data are n (%). COVID-19, coronavirus disease 2019; NIV, non-invasive ventilation; HFNO, high flow nasal oxygen; ICU, intensive care unit, N.A., not applicable
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)Ventilation (architecture)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Intensive care medicineRespiratory failureRespiratory systemEmergency medicineAnesthesiaInternal medicineVirologyInfectious disease (medical specialty)DiseaseEngineeringMechanical engineeringOutbreakRespiratory Support and MechanismsAirway Management and Intubation TechniquesNeuroscience of respiration and sleep